Richard Granstein is a Dermatology physician affiliated with Cornell University. OpenAlex indexes 213 publications with 10,112 citations (h-index 54); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
520 E 70th St # Starr-326
New York, NY 100219800
Telephone
212-746-2007Registry record last updated 15 Sept 2011.
Clinical trials
- Rimegepant in Moderate Plaque-type Psoriasis
Sponsor: Weill Medical College of Cornell University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Corticosteroid100%Fluocinonide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 1995–2015 per NIH RePORTER. The latest:
- Neurotransmitter Regulation of Immunity Through Effects on Endothelial Cells
Weill Medical Coll of Cornell Univ
FY2015$186,450R21AR064907 - Neurotransmitter Regulation of Immunity Through Effects on Endothelial Cells
Weill Medical Coll of Cornell Univ
FY2014$223,740R21AR064907 - Langerhans Cells and Nerves: Bidirectional Signaling
Weill Medical Coll of Cornell Univ
FY2009$343,439R01AR042429
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Roles of calcitonin gene-related peptide in the skin, and other physiological and pathophysiological functions
Brain Behavior & Immunity - Health
2021 - Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee
Journal of the American Academy of Dermatology
2020 - A protective Langerhans cell–keratinocyte axis that is dysfunctional in photosensitivity
Science Translational Medicine
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Devereux, MD
Cornell University
Thomas Walsh, MD
Cornell University
Cora Sternberg, MD
Cornell University
George Alexopoulos, MD
Cornell University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”